Results 51 to 60 of about 28,700 (297)
This study overcomes the challenges of integrating MIPs with nanostructured transducers for chemical sensing. It demonstrates precise MIP deposition on nanoporous silica (PSiO2) via controlled radical photopolymerization, achieving uniform thin films.
Tiziano Di Giulio+8 more
wiley +1 more source
Abstract Purpose To investigate the incidence and risk factors of retinal detachment (RD) and bacterial endophthalmitis in a cohort of children who underwent cataract surgery before the age of eight. Methods Data was retrieved from the Swedish national paediatric cataract register.
Arzu Seyhan Karatepe Hashas+8 more
wiley +1 more source
ABSTRACT Recently, a distinct subgroup of vascular neoplasms has been identified, characterized by NFATC‐related fusions. Although existing literature is limited, these lesions histologically show a variable appearance with a tendency for local recurrence but not distant spread.
B. Schurink+3 more
wiley +1 more source
Topical Timolol Inhibits Corneal Neovascularization in Rabbits [PDF]
Timolol is a non-selective beta-adrenergic antagonist that is similar to propranolol. The mechanism through which these drugs act on the regression of neovascularization is largely unknown.
Farrahi, Fereydoun+5 more
core +4 more sources
Thomas K Mundorf1, Steven H Rauchman2, Robert D Williams3, Ricardo Notivol4, Brinzolamide/Timolol Preference Study Group51Mundorf Eye Center, Charlotte, NC, USA; 2North Valley Eye Medical Group, Mission Hills, CA, USA; 3Taustine Eye Center, Louisville ...
Thomas K Mundorf+4 more
doaj
Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study. [PDF]
PURPOSE: To compare the intraocular pressure (IOP)-lowering effect of latanoprostene bunod (LBN) 0.024% with timolol maleate 0.5% in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Martin, Keith R+5 more
core +1 more source
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension : Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment [PDF]
Funding Information: Sponsorship for this study, publication fees (Rapid Service and Open Access), and medical writing fees were provided by Santen SA.
Kirwan, James+4 more
core +1 more source
Abstract Objective To compare the risk of ischemic stroke in patients with migraine treated with first‐line medications, including valproate, topiramate, metoprolol, timolol, or propranolol, versus those not receiving these treatments, using data from two large electronic health records datasets. Background The impact of first‐line migraine medications
Eugene Jeong+2 more
wiley +1 more source
A comparative study between two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in the co-existence of the probable carcinogenic oxidative degradation product of timolol maleate in their ophthalmic ...
Asmaa A. Mandour+4 more
doaj +1 more source
Pharmaceutical treatment of primary open angle glaucoma [PDF]
Background: Glaucoma is a progressive, irreversible optic neuropathy that results in serious vision loss and blindness. This review aimed to summarize key concepts of primary open angle glaucoma (POAG) pharmaceutical treatment trials over the last decade.
Al-Namaeh , Mashael
core +2 more sources